Answers are grounded in this paper and cite their sources.
INTRODUCTION An omnipresent molecule, melatonin has been observed to be present in almost every living being from bacteria to humans. In vertebrates, besides being produced in peripheral tissues and acting as an autocrine and paracrine signal, melatonin is centrally synthetized by the neuroendocrine organ, the pineal gland.[1] The history of melatonin’s discovery dates to the mid-1950s when melatonin, a pineal active factor that had been studied for 40 years and was named for its ability to aggregate melanin granules within the melanocytes was first isolated by the American Dermatologist Aaron B. Lerner at Yale University School of Medicine. 60 years later, extensive research comprising >23000 other published research articles, have shown that melatonin has myriad functions that encompass every live organism in which its presence was attested with the latest being a new role of melatonin that has been discovered, as a weight loss medication.[1] Thus, melatonin has become an agent considered to be vital for the sustainment of life. Melatonin’s primary discovered role has been circadian clocks, present in all living beings have ripened to allow plants and animals to adapt their behaviors to the 24 h change in the external environment due to the earth’s rotation. With the cloning and characterization of the first drosophila clock gene period in the early 1980s by Jeffery C. Hall and Michael Rosbash cemented pathways for further discoveries of additional genes and proteins and the 2017 Nobel prize in physiology or medicine was awarded to honor their discoveries of molecular mechanisms controlling the circadian rhythm.[2] MELATONIN AND ITS ROLE IN NORMAL PHYSIOLOGY Some facts about melatonin physiology are as follows.[3] Synthesis and secretion Melatonin is a methoxyindole, a chemical compound, synthesized and secreted primarily by the pineal gland. It is produced at night, under normal light/dark conditions. Endogenous rhythm The secretion of melatonin follows a natural rhythm, known as the endogenous rhythm, which is generated by the suprachiasmatic nuclei in the brain. This rhythm is synchronized or entrained to the light/dark cycle, meaning it peaks at night and decreases during the day. Measurement To assess the nycthohemeral (daily) rhythm of melatonin, it can be measured in various ways, such as through repeated measurements of plasma or saliva melatonin levels. Additionally, urine sulfatoxymelatonin, the primary hepatic metabolite of melatonin, can be used as a marker for its production. Physiological function The primary physiological function of melatonin is to convey information about the daily cycle of light and darkness to various body structures. It serves as a kind of biological clock, helping to coordinate and regulate functions that respond to changes in the photoperiod, including seasonal rhythms. Seasonal rhythms Melatonin is involved in the regulation of seasonal rhythms in many animals, including humans. It helps organisms adapt to changes in day length and environmental conditions, influencing processes such as reproduction, sleep-wake cycles, and other biological activities that are influenced by seasonal changes in light exposure. THE PINEAL GLAND AND MELATONIN The pineal gland, located at the geometric center of the human brain and directly connected to the third ventricle, is categorized as a circumventricular organ and plays a role in regulating biological rhythms in vertebrates. In this context, we refer to the system governing these rhythms as the “suprachiasmatic nucleus (SCN)-melatonin loop.” This loop encompasses various components, including melanopsin-containing retinal ganglion cells (MRGC), the retino-hypothalamic tract, the SCN, the paraventricular nucleus, the intermediolateral cell column, the sympathetic cervical ganglia, the pineal gland, and the melatonin rhythm, which, through feedback mechanisms, influences the SCN. Notably, melatonin membrane receptors have been identified in the SCN of vertebrates, and signal transduction pathways involving both MT1 and MT2 receptors have been shown to increase the expression of two clock genes, Period 1 and Period 2.[4] The feedback information provided by melatonin is crucial for the SCN to accurately interpret natural photoperiodic changes. Without this feedback, the SCN would struggle to maintain a proper internal rhythm synchronized with the 24-h day-night cycle, resulting in a free-running rhythm with a longer period than 24 h. Consequently, the SCN would signal the pineal gland to produce melatonin in an abnormal circadian rhythm, also exceeding 24 h. This phenomenon is particularly evident in individuals and animals that are completely blind, as their eyes, specifically the MRGC, do not effectively receive environmental light information. Significantly, the administration of melatonin to blind individuals can partially re-establish their biological rhythms, bringing them closer to a normal daily cycle.[5] The pineal gland is subject to adrenergic innervation, which initiates a series of circadian events culminating in the nightly production of melatonin from serotonin. During the daytime, the pineal gland contains high levels of serotonin, and as night falls, serotonin levels increase further due to the absence of melatonin production. However, when melatonin synthesis is in progress, both 5-hydroxytryptophan and serotonin content in the rat pineal gland dip below their daytime levels, as they are utilized in the process of melatonin synthesis.[6] This upswing in nighttime serotonin synthesis is primarily driven by an increase in enzyme activity and protein levels of tryptophan hydroxylase 1 (TPH 1), which is the rate-limiting enzyme responsible for serotonin production. Posttranslational control, involving the phosphorylation of serine-58, stabilizes the TPH 1 protein, leading to elevated serotonin production during the nighttime hours.[7] Serotonin secretion exhibits a biphasic pattern during the night. It begins with an early peak in amplitude, followed by a sustained decrease in concentration for the remainder of the night. This dynamic fluctuation in serotonin levels plays a key role in the regulation of melatonin production and the circadian rhythms associated with the sleep-wake cycle.[8] As a result, melatonin deficiency can have diverse effects on health and may be linked to neurological, metabolic, and other health issues. Research on melatonin deficiency has primarily focused on studying melatonin levels in various bodily fluids and tissues, including the pineal gland, circulation, saliva, cerebrospinal fluid, and urine (measuring the metabolite 6-sulfatoxymelatonin).[9] It is noted that the peak levels of melatonin at night tend to decrease as individuals age. However, there is significant variability between individuals. Lower melatonin levels, beyond what is expected with normal aging, have been frequently observed in neurodegenerative disorders, particularly Alzheimer’s disease and other forms of senile dementia. In many cases, the melatonin rhythm is severely disrupted, possibly due to degeneration of the SCN.[10] Tissue damage in the SCN or the pineal gland can also lead to reduced melatonin secretion and sleep disturbances. The examples are given, such as juvenile hamartomas and craniopharyngiomas, which can cause precocious puberty and other issues. Melatonin deficiency has been linked to various health conditions, including diabetes type 2, insulin resistance, migraines, severe pain, and certain types of cancer.[11] LIGHT AND MELATONIN PRODUCTION Exposure to nocturnal light, particularly in shift work situations, can acutely suppress melatonin production by the pineal gland. This suppression is distinct from disturbances in the circadian system. The passage mentions that the transient melatonin deficiency induced by nocturnal light exposure in shift workers is not compensated during later sleep phases due to the timing of the circadian clock. Research has explored how the intensity, duration, and spectral properties of light affect melatonin levels in humans. Different lighting conditions can impact melatonin production and disrupt the circadian rhythm. In regions with extreme light conditions, such as the arctic and Antarctic summers, there are reports of moderately reduced melatonin levels. However, the melatonin rhythms are generally maintained, albeit sometimes phase shifted. These changes are not seen as highly pathological except for a possible association with an increased frequency of migraines.[12] MELATONIN METABOLISM After intravenous or oral administration, melatonin is quickly metabolized, mainly in the liver and secondarily in the kidney. Tmax is approximately 50 min following oral immediate-release formulations of melatonin. T1/2 is 45 min in both administration routes. Cmax, area under the curve (AUC), clearance (Cl), and volume of distribution (VD) varies extensively between studies. Bioavailability of oral melatonin was approximately 15%.[13] CIRCADIAN CLOCKS, AGING AND MELATONIN Biological aging is a natural process characterized by the gradual decline in an organism’s functional capacity, physiological health, and physical appearance. Several mechanisms contribute to the aging process, including oxidative stress, mitochondrial dysfunction, disruption of circadian rhythms, inflammation, proteostasis (maintenance of protein function), telomere shortening, genomic instability, epigenetic changes, and a reduced capacity for tissue repair.[14] Circadian clocks play a crucial role in maintaining human health by regulating the rhythmic activities of physiological and neuro-endocrine functions. However, as individuals age, there is a noticeable decline in circadian rhythm and a reduction in the expression of circadian genes. This decline can lead to increased oxidative stress due to the generation and accumulation of reactive oxygen species.[15] Interestingly, melatonin is not exclusively produced by the pineal gland; it is also synthesized in extra-pineal tissues, including human skin. In the skin, melatonin serves as a multifunctional molecule and follows a rhythmic production pattern, with the highest levels observed in the evening. Cutaneous melatonin production in the skin has a protective effect against damage caused by external factors. Melatonin and its various metabolites, such as 6-hydroxymelatonin, 2-hydroxymelatonin, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK), and N1-acetyl-5-methoxykynuramine (AMK), help limit oxidative stress by scavenging harmful radicals and inhibiting their generation, particularly at the mitochondrial level. Additionally, melatonin stimulates the production of antioxidant enzymes, further enhancing its antioxidant properties. Melatonin can also mitigate DNA damage caused by environmental factors and exhibits anti-inflammatory and anti-apoptotic effects.[16] The diverse and potent regulatory actions of melatonin and its metabolites on the skin make them effective anti-aging agents. Since the synthesis of peripheral melatonin decreases with age, the topical application of melatonin is considered a promising strategy to enhance endogenous cutaneous melatonin production. This approach is seen as an effective means of photoprotection and a highly promising anti-aging strategy.[17] MELATONIN AND SLEEP Melatonin appears to be a promising treatment option for improving sleep in children and adolescents, particularly in cases where sleep disturbances are associated with neurodevelopmental disorders which may include conditions such as autism spectrum disorder, attention-deficit hyperactivity disorder, or other developmental conditions that can affect sleep patterns. Findings suggest that melatonin supplementation can lead to increased total sleep time and reduced sleep latency, as reported in sleep diaries. However, it is important to consult with health-care professionals for individualized recommendations and to ensure safe and appropriate use of melatonin in pediatric populations. An increase in melatonin prescriptions for children and adolescents has been observed over the last decade.[18] Melatonin was associated with a moderate increase in total sleep time, with an average increase of approximately 30 min. This improvement was measured using sleep diaries. It was also found to have a moderate reducing effect on sleep latency, with an average reduction of about 18 min.[19] Administration of physiologic doses (0.1–0.3 mg) of melatonin promotes sleep onset and maintenance, decreases sleep latency, increases sleep efficiency, and improves total sleep time.[20] However, the number of controlled clinical trials is still small, and specific studies to resolve problems of dosage, formulations (slow or fast release), and length of treatment are desirable. MELATONIN AND MOOD Recent findings also indicate that melatonin has profound epigenetic influences that could influence mood through up regulation of MT1 and MT2 receptor expression in the brain following treatment with this drug. Whereas some actions are mediated directly, others involve melatonin receptors. This leads to the interesting possibility that valproate, either alone or in combination with melatonin, could have beneficial effects in treating neurological and psychiatric disorders that are associated with a functional deficit in melatonin and/or its receptors. A study suggests that melatonin may have potential therapeutic benefits in a range of medical conditions by enhancing the function of enzymes involved in the pentose phosphate pathway (PPP). The PPP is a metabolic pathway in cells that plays a crucial role in various cellular processes, including the generation of nicotinamide adenine dinucleotide phosphate and the production of ribose-5-phosphate for nucleotide synthesis. Melatonin could be beneficial in neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease. These conditions involve the degeneration of neurons and are associated with oxidative stress and mitochondrial dysfunction. Enhancing PPP enzyme function may help mitigate some of the cellular damage associated with these diseases. Melatonin may also have applications in conditions related to the retina, such as light-sensitive retinopathies. The retina is highly sensitive to oxidative stress, and melatonin’s potential ability to enhance PPP enzymes could help protect retinal cells from damage caused by light exposure. The passage hints at melatonin’s potential benefits for cognition. Oxidative stress and mitochondrial dysfunction can impact cognitive function, and by improving the cellular defence mechanisms through PPP enzymes, melatonin might have a positive impact on cognitive health.[21,22] SOME CLINICALLY RELEVANT FACTS Clinically, we must enquire in history about alcohol and caffeine intake of our patients. Caffein intake history post 4 PM, blue light exposure and screen exposure, history of time zone travel and jet lag on a frequent basis, shift works and changes in sleep cycles all point toward melatonin deficiency. These patients may benefit with melatonin therapy[23] Melatonin has positive far reaching anti-inflammatory action in disorders such as rheumatoid arthritis, systemic lupus erythematosus, diabetes, and inflammatory bowel disease. Thus, it may be used as a medication to help with sleep issues in these conditions while also contributing toward systemic improvement[24] Melatonin-1 receptors are primary cerebral and hypothalamic and exert effects on sleep and hence selective melatonin agonists such as Ramelteon have been used for the management of insomnia.[25] However, there are no head on studies to show that Ramelteon is superior to melatonin in the same regard. Melatonin-2 receptors are more subcortical and peripheral and recently discovered melatonin-3 receptors are located in the mitochondria[26] Synthetic melatonin and plant-based melatonin are both effective in the management of the sleep wake cycle and treatment of insomnia. There have been no differences found in their efficacy, but patients may prefer plant-based products due to their herbal and organic nature. Melatonin combined with chamomile, green tea extracts, and magnesium with Vitamin B6 are also available as sleep inducing and anti-stress over-the-counter medication.[27] Melatonin thus has deep physiological implications and must be used as a safe alternative to other agents in the induction of sleep and modulation of the sleep-wake cycle. It can be used safely across all age groups and is devoid of any major side effects. Further research in diverse populations and comparison to other agents across various populations is warranted
No takes yet. Share an insight, caveat, or question.
Motwani et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: